Our results establish a workflow for profiling protease activity across multiple scales–at the organism, tissue, and cellular levels–and demonstrate the utility of our methods for noninvasive monitoring and functional characterization of tumor progression and treatment response, showcased in the context of Alk-mutant lung cancer treated with targeted therapy (Fig. 1). This evidence concerns the gene ALK and neoplasm.